Dimick JB . Potential benefits of the new Leapfrog standards: effect of process and outcomes measures . Surgery. 2004 ; 135 : 569 – 575 . 18 Stein JP Lieskovsky G Cote R . Radical cystectomy in the treatment of invasive bladder cancer
Brent K. Hollenbeck, James E. Montie and John T. Wei
Paolo Dell'Oglio, Zhe Tian, Sami-Ramzi Leyh-Bannurah, Vincent Trudeau, Alessandro Larcher, Marco Moschini, Ettore Di Trapani, Umberto Capitanio, Alberto Briganti, Francesco Montorsi, Fred Saad and Pierre I. Karakiewicz
Background Radical cystectomy (RC) is one of the most invasive surgeries in urologic oncology, with an elevated perioperative mortality that can reach 14.8% in elderly patients, according to the SEER-Medicare database. 1 SEER
Richard S. Matulewicz, Brendan T. Frainey, Daniel T. Oberlin and Joshua J. Meeks
cancer-specific mortality for T1HG bladder cancer are high (53% and 34%, respectively) from single-institutional series. 1 In 2001, Herr et al 1 suggested that early radical cystectomy (RC) may improve the survival of patients with high-risk superficial
Ronald C. Chen, William U. Shipley, Jason A. Efstathiou and Anthony L. Zietman
illnesses, such as cardiovascular disease. 3 , 4 Radical cystectomy is commonly considered a standard treatment for MIBC, and its efficacy and morbidity profile are well described. 5 Radical cystectomy involves removal of the bladder with a lymph node
William C. Huang and Bernard H. Bochner
dissection, and bilateral uretero-enterostomy . J Urol 1950 ; 63 : 242 – 260 . 4. Mills RD Turner WH Fleischmann A . Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy
James E. Montie, Peter E. Clark, Mario A. Eisenberger, Rizk El-Galley, Richard E. Greenberg, Harry W. Herr, Gary R. Hudes, Deborah A. Kuban, Timothy M. Kuzel, Paul H. Lange, Subodh M. Lele, Jeffrey Michalski, Anthony Patterson, Kamal S. Pohar, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Phillip J. Walther and Timothy G. Wilson
. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy . J Urol 2001 ; 166 : 490 – 493 . 9 Schwaibold HE Sivalingam S May F Hartung R . The value of a second transurethral resection for T1
Harry W. Herr
(A) immediate cystectomy versus (B) surveillance or delayed cystectomy. Abbreviations: DOC, death from other causes; DOD, dead of disease; DUC, death from unknown causes; RC, radical cystectomy; TUR, transurethral resection. nonrandomized
Michael Karass, Rohan Bareja, Ethan Shelkey, Panagiotis J. Vlachostergios, Brian D. Robinson, Francesca Khani, Juan Miguel Mosquera, Douglas S. Scherr, Andrea Sboner, Scott T. Tagawa, Ana M. Molina, Olivier Elemento, David M. Nanus and Bishoy M. Faltas
, gemcitabine/cisplatin; LNs, lymph nodes; NMIBC, non–muscle-invasive bladder cancer; RARC, robot-assisted radical cystectomy; UC, urothelial cancer. The patient was referred for systemic therapy and was enrolled in the CALGB 90601 randomized phase III trial
Nalan Nese, Ruta Gupta, Matthew H. T. Bui and Mahul B. Amin
Edited by Kerrin G. Robinson
: 1161 – 1163 [in French] . 53 Joudi FN Konety BR . The impact of provider volume on outcomes from urological cancer therapy . J Urol 2005 ; 174 : 432 – 438 . 54 Chang SS Cookson MS . Radical cystectomy for bladder cancer: the
S. Machele Donat
Cancer J Clin 2008 : 58 : 71 – 96 . 2 Stein JP Lieskovsky G Cote R . Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients . J Clin Oncol 2001 ; 19 : 666 – 675 . 3 Dalbagni G Genega
